QUINCE THERAPEUTICS, INC.

Transcripts Quince Therapeutics, Inc.

Equities

QNCX

US22053A1079

Delayed Nasdaq Other stock markets 21:00:00 07/05/2024 BST			5-day change	1st Jan Change
0.92 ^USD	-4.17%		-14.02%	-12.38%

04-01	Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-26	Transcript : Quince Therapeutics, Inc. - Special Call

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Quince Therapeutics, Inc. - Special Call	03-26
Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call	24/05/23
Transcript : Cortexyme, Inc. - Special Call	26/10/21
Transcript : Cortexyme, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM	13/09/21
Transcript : Cortexyme, Inc. - Special Call	30/07/21
Transcript : Cortexyme, Inc. - Special Call	23/07/21
Transcript : Cortexyme, Inc. Presents at The JMP Securities Life Sciences Conference, Jun-16-2021 03:00 PM	16/06/21
Transcript : Cortexyme, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 02:00 PM	02/06/21
Transcript : Cortexyme, Inc. Presents at Stifel's 3rd Annual CNS Day, Apr-01-2021 10:00 AM	01/04/21
Transcript : Cortexyme, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 02:30 PM	16/03/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer